Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ
Watchlist
Price: 16.21 EUR 3.25%
Market Cap: 337.9m EUR
Section:
 

Relative Value

The Relative Value of one EUZ stock under the Base Case scenario is 17.58 EUR. Compared to the current market price of 16.21 EUR, Eckert & Ziegler Strahlen und Medizintechnik AG is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EUZ Relative Value
Base Case
17.58 EUR
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
57
vs Industry
30
Median 3Y
3.2
Median 5Y
3.6
Industry
2.4
Forward
3.2
More Details
25.6
P/E
P/E
Price to Earnings
25.6
vs History
73
vs Industry
13
Median 3Y
27.5
Median 5Y
29.5
Industry
22.9
Forward
16.8
More Details
15.3
P/OCF
P/OCF
Price to OCF
15.3
vs History
80
vs Industry
17
Median 3Y
17.5
Median 5Y
20.7
Industry
14.7
More Details
30.6
P/FCFE
P/FCFE
Price to FCFE
30.6
vs History
71
vs Industry
5
Median 3Y
33.4
Median 5Y
61.2
Industry
21.4
More Details
4.4
P/B
P/B
Price to Book Value
4.4
vs History
44
vs Industry
17
Median 3Y
3.8
Median 5Y
4.3
Industry
2.3
More Details
3.1
EV/S
EV/S
Enterprise Value to Sales
3.1
vs History
60
vs Industry
29
Median 3Y
3
Median 5Y
3.4
Industry
2.6
Forward
2.9
More Details
6.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.5
vs History
60
vs Industry
26
Median 3Y
6.3
Median 5Y
7.1
Industry
5.3
More Details
10.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.9
vs History
79
vs Industry
23
Median 3Y
12
Median 5Y
13.1
Industry
12.3
Forward
10.2
More Details
14.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.4
vs History
77
vs Industry
24
Median 3Y
15.6
Median 5Y
17
Industry
17.2
Forward
12.4
More Details
14
EV/OCF
EV/OCF
Enterprise Value to OCF
14
vs History
85
vs Industry
18
Median 3Y
16.8
Median 5Y
19.3
Industry
15
More Details
21.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.1
vs History
80
vs Industry
14
Median 3Y
38.7
Median 5Y
47.7
Industry
19
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
44
vs Industry
27
Median 3Y
2.3
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

EUZ Competitors Multiples
Eckert & Ziegler Strahlen und Medizintechnik AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ
1B EUR 3.3 25.6 10.9 14.4
US
Abbott Laboratories
NYSE:ABT
219B USD 5 15.7 20 27.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
210.2B USD 21.9 76.5 58.7 71.6
US
Boston Scientific Corp
NYSE:BSX
144.7B USD 7.5 51.9 30.3 41.2
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.7 23.2 28.2
IE
Medtronic PLC
NYSE:MDT
125B USD 3.6 26.2 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.2 24.4 13.7 19.3
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD 2.6 34.5 12.7 21.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.1B USD 13.7 55.5 39.9 44.2
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD 8.4 36.1 25.8 28.3
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.8B USD 2 17.9 13.3 16.1

See Also

Summary
EUZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
EUZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EUZ stock valuation using valuation multiples.
Wall Street Estimates
EUZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EUZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.